{"id":30544,"date":"2022-04-29T07:55:04","date_gmt":"2022-04-29T13:55:04","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=30544"},"modified":"2022-04-29T07:55:50","modified_gmt":"2022-04-29T13:55:50","slug":"brakke-viewpoint-april-29-2022","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-29-2022\/","title":{"rendered":"\u5e03\u62c9\u514b\u89c2\u70b9 2022 \u5e74 4 \u6708 29 \u65e5"},"content":{"rendered":"<p>IQVIA \u7814\u7a76\u6240\u6700\u8fd1\u53d1\u5e03\u7684\u4e00\u4efd\u62a5\u544a\u9898\u4e3a\u201c<a href=\"https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports\/the-use-of-medicines-in-the-us-2022?utm_source=seeking_alpha&amp;utm_campaign=rta-stock-news&amp;messageid=2900&amp;mailingid=27472403&amp;serial=27472403.24539&amp;utm_term=27472403.24539&amp;source=email_2900&amp;utm_medium=email\">2022 \u5e74\u7f8e\u56fd\u836f\u7269\u4f7f\u7528\u60c5\u51b5<\/a>\u5982\u679c\u60a8\u76f8\u4fe1\u4eba\u7c7b\u533b\u5b66\u7684\u53d1\u5c55\u8d8b\u52bf\u6700\u7ec8\u4f1a\u4f53\u73b0\u5728\u517d\u533b\u5b66\u4e2d\uff0c\u90a3\u4e48\u8fd9\u672c\u4e66\u5c06\u4f1a\u975e\u5e38\u6709\u8da3\u3002\u4e00\u4e9b\u503c\u5f97\u6ce8\u610f\u7684\u7ed3\u679c\u2026\u2026<\/p>\n<p>\u9996\u5148\uff0c\u8fdc\u7a0b\u533b\u7597\u7684\u603b\u4f53\u4f7f\u7528\u91cf\u5728 2021 \u5e74\u5e95\u5df2\u6062\u590d\u5230\u75ab\u60c5\u524d\u7684\u6c34\u5e73\uff0c\u5373\u60a3\u8005\u5c31\u8bca\u91cf\u4e3a 1-2%\u3002\u75ab\u60c5\u671f\u95f4\uff0c\u5fc3\u7406\u5065\u5eb7\u9886\u57df\u7684\u8fdc\u7a0b\u533b\u7597\u4f7f\u7528\u91cf\u6025\u5267\u589e\u52a0\uff0c\u5cf0\u503c\u7ea6\u4e3a\u6240\u6709\u5c31\u8bca\u91cf\u7684 30%\uff0c\u76ee\u524d\u7ea6\u4e3a 20%\u3002\u9ad8\u8840\u538b\u3001\u7cd6\u5c3f\u75c5\u548c\u827e\u6ecb\u75c5\u6bd2\/\u827e\u6ecb\u75c5\u7b49\u6162\u6027\u75c5\u7684\u8fdc\u7a0b\u533b\u7597\u5c31\u8bca\u91cf\u5cf0\u503c\u5728 5 \u81f3 11% \u4e4b\u95f4\uff0c\u4f46\u73b0\u5728\u5df2\u964d\u81f3 1-2%\uff0c\u56e0\u4e3a\u8fd9\u4e9b\u75be\u75c5\u7ecf\u5e38\u9700\u8981\u68c0\u6d4b\u548c\u9a8c\u8840\u3002<\/p>\n<p>\u5176\u6b21\uff0c\u7f8e\u56fd\u4e13\u79d1\u836f\u7269\u652f\u51fa\u5360\u5236\u9020\u5546\u603b\u51c0\u6536\u5165\u7684 55%\u3002\u8fd9\u4e9b\u836f\u7269\u7528\u4e8e\u6cbb\u7597\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u3001\u80bf\u7624\u548c\u591a\u53d1\u6027\u786c\u5316\u75c7\uff0c\u76ee\u524d\u7ea6\u4e3a 2011 \u5e74\u6c34\u5e73\uff0828%\uff09\u7684\u4e24\u500d\u3002<\/p>\n<p>\u6700\u540e\uff0c\u8fc7\u53bb 5 \u5e74\u533b\u836f\u652f\u51fa\u7684\u6240\u6709\u589e\u957f\uff08$820 \u4ebf\uff09\u90fd\u5f52\u56e0\u4e8e\u65b0\u4ea7\u54c1\uff08$877 \u4ebf\uff09\u3002\u5df2\u4e0a\u5e02\u4e13\u5229\u4ea7\u54c1\u7684\u6570\u91cf\u5f71\u54cd\uff08+$94 \u4ebf\uff09\u5b8c\u5168\u88ab\u4e13\u5229\u5230\u671f\u4ea7\u54c1\u6240\u62b5\u6d88\uff08-$930 \u4ebf\uff09\u3002<\/p>\n<p>\u517d\u533b\u5b66\u901a\u5e38\u8ffd\u968f\u4eba\u7c7b\u5065\u5eb7\u7684\u811a\u6b65\uff0c\u90a3\u4e48\u6211\u4eec\u53ef\u4ee5\u4ece\u8fd9\u4efd\u62a5\u544a\u4e2d\u5b66\u5230\u4ec0\u4e48\u5462\uff1f\u4e13\u6ce8\u4e8e\u4e13\u4e1a\u4ea7\u54c1\u7684\u521b\u65b0\u53ef\u80fd\u4f1a\u63a8\u52a8\u517d\u533b\u5b66\u672a\u6765\u7684\u589e\u957f\uff0c\u800c\u8fdc\u7a0b\u533b\u7597\u7b49\u670d\u52a1\u521b\u65b0\u5c06\u66f4\u96be\u63a8\u5e7f\u3002<\/p>\n<p><em>\u9c8d\u52c3\u00b7\u743c\u65af<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>\u5982\u679c\u60a8\u76f8\u4fe1\u4eba\u7c7b\u533b\u5b66\u7684\u8d8b\u52bf\u6700\u7ec8\u4f1a\u5728\u517d\u533b\u5b66\u4e2d\u5f97\u5230\u4f53\u73b0\uff0c\u90a3\u4e48 IQVIA \u7814\u7a76\u6240\u6700\u8fd1\u53d1\u5e03\u7684\u4e00\u4efd\u9898\u4e3a\u201c2022 \u5e74\u7f8e\u56fd\u836f\u7269\u4f7f\u7528\u60c5\u51b5\u201d\u7684\u62a5\u544a\u503c\u5f97\u4e00\u8bfb\u3002\u62a5\u544a\u5f97\u51fa\u4e86\u4e00\u4e9b\u663e\u8457\u7684\u7ed3\u8bba\u2026\u2026\u9996\u5148\uff0c2021 \u5e74\u5e95\uff0c\u8fdc\u7a0b\u533b\u7597\u7684\u603b\u4f53\u4f7f\u7528\u60c5\u51b5\u5df2\u6062\u590d\u5230\u75ab\u60c5\u524d\u7684\u6c34\u5e73\uff0c\u5360\u60a3\u8005\u5c31\u8bca\u6b21\u6570\u7684 1-2%\u3002\u75ab\u60c5\u671f\u95f4\uff0c\u7cbe\u795e\u5065\u5eb7\u9886\u57df\u7684\u8fdc\u7a0b\u533b\u7597\u4f7f\u7528\u91cf\u6025\u5267\u589e\u52a0\uff0c\u5cf0\u503c\u7ea6\u4e3a\u6240\u6709\u5c31\u8bca\u6b21\u6570\u7684 30%\uff0c\u73b0\u5728\u7ea6\u4e3a 20%\u3002\u9ad8\u8840\u538b\u3001\u7cd6\u5c3f\u75c5\u548c\u827e\u6ecb\u75c5\u6bd2\/\u827e\u6ecb\u75c5\u7b49\u6162\u6027\u75be\u75c5\u7684\u8fdc\u7a0b\u533b\u7597\u5c31\u8bca\u6b21\u6570\u5cf0\u503c\u5728 5 \u81f3 11% \u4e4b\u95f4\uff0c\u4f46\u73b0\u5728\u5df2\u964d\u81f3 1-2%\uff0c\u56e0\u4e3a\u8fd9\u4e9b\u75be\u75c5\u901a\u5e38\u9700\u8981\u68c0\u6d4b\u548c\u9a8c\u8840\u3002\u5176\u6b21\uff0c\u7f8e\u56fd\u4e13\u79d1\u836f\u7269\u7684\u652f\u51fa\u5360\u5236\u9020\u5546\u603b\u51c0\u6536\u5165\u7684 55%\u3002\u8fd9\u4e9b\u836f\u7269\u7528\u4e8e\u6cbb\u7597\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u3001\u80bf\u7624\u548c\u591a\u53d1\u6027\u786c\u5316\u75c7\uff0c\u76ee\u524d\u7ea6\u4e3a2011\u5e74\u6c34\u5e73\uff0828%\uff09\u7684\u4e24\u500d\u3002\u6700\u540e\uff0c\u8fc7\u53bb\u4e94\u5e74\u836f\u54c1\u652f\u51fa\u7684\u6240\u6709\u589e\u957f\uff08$82.0B\uff09\u5747\u6e90\u4e8e\u65b0\u4ea7\u54c1\uff08$87.7B\uff09\u3002\u5df2\u4e0a\u5e02\u4e13\u5229\u4ea7\u54c1\uff08+$94B\uff09\u7684\u9500\u91cf\u5f71\u54cd\u5b8c\u5168\u88ab\u4e13\u5229\u5230\u671f\u4ea7\u54c1\uff08-$93.0B\uff09\u62b5\u6d88\u3002\u517d\u836f\u901a\u5e38\u8ffd\u968f\u4eba\u7c7b\u5065\u5eb7\u7684\u811a\u6b65\uff0c\u90a3\u4e48\u6211\u4eec\u53ef\u4ee5\u4ece\u8fd9\u4efd\u62a5\u544a\u4e2d\u5b66\u5230\u4ec0\u4e48\u5462\uff1f\u4e13\u6ce8\u4e8e\u4e13\u79d1\u4ea7\u54c1\u7684\u521b\u65b0\u53ef\u80fd\u4f1a\u63a8\u52a8\u517d\u836f\u672a\u6765\u7684\u589e\u957f\uff0c\u800c\u670d\u52a1\u9886\u57df\u7684\u521b\u65b0\uff0c\u4f8b\u5982<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-29-2022\/\" class=\"view-full-post-btn\">\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n<p>;<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[43],"tags":[],"class_list":["post-30544","post","type-post","status-publish","format-standard","hentry","category-viewpoints"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-29-2022\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"A recent report from the IQVIA Institute entitled \u201cThe Use of Medicines in the US 2022\u201d is interesting reading if you believe that trends in human medicine eventually show up in veterinary medicine.\u00a0 Some notable results\u2026 First, the overall use of telehealth has returned to pre-pandemic levels at the end of 2021, or 1-2% of patient visits.\u00a0 Mental health saw dramatic increases in telehealth during the pandemic, peaking at about 30% of all visits, and is now about 20%.\u00a0 Telehealth visits for chronic diseases, like hypertension, diabetes, and HIV\/AIDS, peaked between 5 to 11% of visits, but are now down to 1-2%, because these diseases frequently require testing and bloodwork. Second, spending on specialty medicines in the US is 55% of total net manufacturer revenue.\u00a0 These medicines treat autoimmune diseases, oncology, and multiple sclerosis and is now about double the 2011 level, which was 28%. Finally, all the growth in medicine spending in the past 5 years, ($82.0B) has been due to new products ($87.7B).\u00a0 The volume impact of patented products already launched (+$94B) was completely offset by products going off patent (-$93.0B). Veterinary medicine often follows in the footsteps of human health, so what can we learn from this report? Innovation focused on specialty products is likely to drive future growth in veterinary medicine, while innovation in services, likeView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-29-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-29T13:55:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-29T13:55:50+00:00\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"Brakke Viewpoint April 29, 2022\",\"datePublished\":\"2022-04-29T13:55:04+00:00\",\"dateModified\":\"2022-04-29T13:55:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/\"},\"wordCount\":223,\"articleSection\":[\"Viewpoints\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2022-04-29T13:55:04+00:00\",\"dateModified\":\"2022-04-29T13:55:50+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brakke Viewpoint April 29, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/amanda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-29-2022\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"A recent report from the IQVIA Institute entitled \u201cThe Use of Medicines in the US 2022\u201d is interesting reading if you believe that trends in human medicine eventually show up in veterinary medicine.\u00a0 Some notable results\u2026 First, the overall use of telehealth has returned to pre-pandemic levels at the end of 2021, or 1-2% of patient visits.\u00a0 Mental health saw dramatic increases in telehealth during the pandemic, peaking at about 30% of all visits, and is now about 20%.\u00a0 Telehealth visits for chronic diseases, like hypertension, diabetes, and HIV\/AIDS, peaked between 5 to 11% of visits, but are now down to 1-2%, because these diseases frequently require testing and bloodwork. Second, spending on specialty medicines in the US is 55% of total net manufacturer revenue.\u00a0 These medicines treat autoimmune diseases, oncology, and multiple sclerosis and is now about double the 2011 level, which was 28%. Finally, all the growth in medicine spending in the past 5 years, ($82.0B) has been due to new products ($87.7B).\u00a0 The volume impact of patented products already launched (+$94B) was completely offset by products going off patent (-$93.0B). Veterinary medicine often follows in the footsteps of human health, so what can we learn from this report? Innovation focused on specialty products is likely to drive future growth in veterinary medicine, while innovation in services, likeView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-29-2022\/","og_site_name":"Brakke Consulting Website","article_published_time":"2022-04-29T13:55:04+00:00","article_modified_time":"2022-04-29T13:55:50+00:00","author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Amanda McDavid","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"Brakke Viewpoint April 29, 2022","datePublished":"2022-04-29T13:55:04+00:00","dateModified":"2022-04-29T13:55:50+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/"},"wordCount":223,"articleSection":["Viewpoints"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/","url":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2022-04-29T13:55:04+00:00","dateModified":"2022-04-29T13:55:50+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-april-29-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Brakke Viewpoint April 29, 2022"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"\u963f\u66fc\u8fbe\u00b7\u9ea6\u514b\u6234\u7ef4","url":"https:\/\/brakkeconsulting.com\/zh\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/30544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=30544"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/30544\/revisions"}],"predecessor-version":[{"id":30545,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/30544\/revisions\/30545"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=30544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=30544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=30544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}